Delayed MS Decision and Trial Miss Add to Sanofi’s R&D Challenges

Sanofi (NASDAQ:SNY) is included among the 15 Global Dividend Stocks to Diversify Your Portfolio. Delayed MS Decision and Trial Miss Add to Sanofi’s R&D Challenges Sanofi (NASDAQ:SNY) said on December 15 that a US regulatory decision for its experimental multiple sclerosis drug will be delayed again. On the same day, the company also disclosed weaker-than-expected results from a late-stage clinical study, adding to a difficult stretch for its research pipeline. Analysts said the latest setbacks could we ...